Substance abuse patterns and their association with psychopathology and type of hostility in male patients with borderline and antisocial personality disorder

Comprehensive Psychiatry

Volumn 40, Issue 4, 1999, Pages 278-282

  Hatzitaskos, Pavlos ^a   Soldatos, Constantin R ^b   Kokkevi, Anna ^b   Stefanis, Costas N ^b  

^a IASO GENERAL HOSPITAL   (Greece)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CANNABIS; CHOLINERGIC RECEPTOR BLOCKING AGENT; OPIATE;

ADULT; ANTISOCIAL BEHAVIOR; ARTICLE; BORDERLINE STATE; CLINICAL ARTICLE; COMORBIDITY; DISEASE ASSOCIATION; HOSTILITY; HUMAN; MALE; PSYCHOANALYSIS; QUESTIONNAIRE; SUBSTANCE ABUSE;

EID: 0033056537     PISSN: 0010440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-440X(99)90128-1     Document Type: Article

References (31)

1. Pope H, Jonas J, Hudson J, Cohen B, Gunderson J. The validity of DSM III borderline personality disorder. Arch Gen Psychiatry 1983;142:1285-1290.
2. Frances A, Clarkin J, Gilmore M, Hurt S, Brown R. Reliability of criteria for borderline personality disorder: a comparison of DSM III and DIB. Am J Psychiatry 1984;141: 1080-1084.
3. Baxter L, Edell W, Gerner R, Fairbanks L, Gwirtsman H. Dexamethasone suppression test and axis I diagnosis of inpatients with DSM III borderline personality disorder. J Clin Psychiatry 1984;45:150-153.
4. Akiskal H, Chen S, Davis G, Puzantian V, Kashgarian M, Bolinger J. Borderline: an adjective in search of a noun. J Clin Psychiatry 1985;46:41-48.
5. Perry J, Cooper S. Psychodynamics, symptoms, and outcome in borderline and antisocial personality disorders and bipolar type II affective disorder. In: McGlashan T (ed): The Borderline: Current Empirical Research. Washington, DC: American Psychiatric Press, 1985:21-41.
6. Links P, Steiner M, Oxford D, Eppel A. Characteristics of borderline personality disorder: a Canadian study. Can J Psychiatry 1988;33:336-340.
7. Fyer M, Frances A, Sullivan T, Hurt S, Clarkin J. Comorbidity of borderline personality disorder. Arch Gen Psychiatry 1988;45:348-352.
8. Zanarini M, Gunderson J, Frankenburg F. Axis I phenomenology of borderline personality disorder. Compr Psychiatry 1989;30:149-156.
9. Dulit R, Fyer M, Haas G, Sullivan T, Frances A. Substance use in borderline personality disorder. Am J Psychiatry 1990; 147: 1002-1007.
10. Kokkevi A, Stefanis C. Drug abuse and psychiatric comorbidity. Compr Psychiatry 1995;36:329-337.
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Ed. 3. Washington, DC: American Psychiatric Association, 1980.
12. Hollingshead A, Redlich F. Social Class and Mental Illness: A Community Study. New York, NY: Wiley, 1959.
13. Hatzitaskos P, Soldatos CR, Sakkas P, Stefanis CN. Discriminating borderline from antisocial personality disorder in male patients based on psychopathology patterns and type of hostility. J Nerv Ment Dis 1997;185:442-446.
14. Overall J, Gorham D. The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799-812.
15. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
16. Spielberger C, Gorsuch R, Lushene R. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologist Press, 1970.
17. Caine T, Foulds G, Hope K. Manual of the Hostility and Direction of Hostility Questionnaire (HDHQ). London, UK: University of London Press, 1967.
18. Nie N, Hall C, Jenkins J, Steinbrenner K, Bent D. Statistical Package for the Social Sciences. New York, NY: McGraw Hill, 1980.
19. Madianou D, Madianos M, Kokkevi A, Stefanis K. Substance use in the general population. Results from a nation-wide study. In: Stefanis K (ed): Drug Use in Greece. Vol. 3. Athens, Greece: Psychiatric Library, 1992.
20. Mirin SM, Weiss RD. Substance abuse and mental illness. In: Frances RJ, Miller SI (eds): Clinical Textbook of Addictive Disorders. New York, NY: Guilford, 1991.
21. Liappas J, Pomini V, Kokkevi A, Papavasiliou P, Stefanis C. Users contacting a drug clinic in Greece. I: profile of the users. Itaca 1996;1:39-48.
22. Alevizos B, Hatzitaskos P, Stefanis C. Use and abuse of tranquilizers in Greece. In: Piotrowski A, Leder S, Gawronska B (eds): Alcoholism and Other Dependencies. Warsaw, Poland: Polish Psychiatric Association, 1989:20-24.
23. Goodman-Gilman A, Rail T, Nies A, Taylor P (eds). Goodman-Gilman's The Pharmacologic Basis of Therapeutics. Ed. 8. Vol. 1. New York, NY: Pergamon, 1990:475-479.
24. Rounsaville B, Weissman M, Kleber H, Wilber C. Heterogeneity of psychiatric diagnosis in treated opiate addicts. Arch Gen Psychiatry 1982;39:161-166.
25. Khantzian E, Treece C. DSM III psychiatric diagnosis of narcotic addicts. Arch Gen Psychiatry 1985;42:1067-1071.
26. Khantzian E. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry 1985;142:1259-1264.
27. Stefanis CN, Kokkevi A. Depression and drug use. Psychopathology 1986;19(2 Suppl):124-131.
28. Bukstein O, Brent D, Kaminer Y. Comorbidity of substance abuse and other psychiatric disorders in adolescents. Am J Psychiatry 1989;146:1131-1141.
29. Regier D, Farmer M, Rae D, Locke B, Keith S, Judd L, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990;264:2511-2518.
30. Madianos M, Madianou D, Stefanis C. Symptoms of depression, suicidal behaviour and use of substances in Greece: a nationwide general population survey. Acta Psychiatr Scand 1994;89:159-166.
31. Madianos M, Gefou-Madianou D, Richardson C, Stefanis CN. Factors affecting illicit and licit drug use among adolescents and young adults in Greece. Acta Psychiatr Scand 1995;91:258-264.